Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another
Open Access
- 15 August 2001
- Vol. 92 (4), 959-968
- https://doi.org/10.1002/1097-0142(20010815)92:4<959::aid-cncr1406>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation CarriersJNCI Journal of the National Cancer Institute, 1999
- Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancerThe Lancet, 1999
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast CancerNew England Journal of Medicine, 1999
- Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc CommitteeAnnals Of Oncology, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish womenCancer, 1997
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997
- Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to CancerJAMA, 1997
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994